What to Watch For in UnitedHealth Earnings
UnitedHealth is scheduled to report its second-quarter financial results before the markets open on Tuesday.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 128
What to Expect When Johnson & Johnson Reports Tuesday Morning
Johnson & Johnson is set to report its second-quarter financial results before the markets open on Tuesday.
Why Tonix Pharmaceuticals Is Winning Big on Monday
Tonix Pharmaceuticals saw its shares make a solid gain to start off the week after the company announced an update from the FDA regarding its Alzheimer’s agitation treatment.
FDA Warns of Potential Hoax Letters
The FDA issued a warning early on Friday that consumers should be on the lookout for criminals forging FDA warning letters.
Will Acceleron Pharma Momentum Continue After New FDA Nod?
Acceleron Pharma shares dipped on Friday after the company provided an update on an orphan drug designation from the FDA.
How Zogenix Is Winning Big With Late-Stage Seizure Study
Zogenix shares made a solid gain on Thursday after the company announced positive results from its late-stage seizure trial.
Where Did Major Pharma Short Sellers Go?
The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Short Sellers Back Off Major Biotechs
The June 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Akcea Therapeutics Jumps on European Marketing Approval
Akcea Therapeutics shares saw a nice bump on Wednesday after the company announced in conjunction with Ionis Pharmaceuticals that they had received a marketing authorization approval from the European Commission.
BioCryst Shareholders Back Out of Idera Merger
Idera Pharmaceuticals shares crumbled on Wednesday after BioCryst Pharmaceuticals announced that it terminated the merger agreement.
AbbVie Slumps on Late-Stage Lymphoma Trial
AbbVie shares dipped on Wednesday after the company gave a less than impressive update from its late-stage lymphoma trial.
Replimune Closes in on IPO
Biotechnology company Replimune intends to price more than 6 million shares in an initial public offering valued up to more than $123 million.
Celgene and Acceleron Pharma Win Again in Late-Stage Trial
Acceleron Pharma and Celgene each saw a handy gain on Tuesday morning after it was announced results from their late-stage study in adults with transfusion-dependent beta-thalassemia.
Axovant Wins With Key Licensing Agreement
Axovant Sciences shares saw a handy gain on Monday after the company announced that it has licensed exclusive global rights to an investigational gene therapy program from Benitec Biopharma.
Constellation Pharma Closes in on IPO
Constellation Pharmaceuticals intends to price more than 5 million shares to result in an initial public offering valued up to more than $98 million.